{"id":203601,"name":"ULTRAGENYX PHARMACEUTICAL","slug":"ultragenyx-pharmaceutical","state":"CA","country":"United States of America","description":"Clinical-stage biotechnology company focused on debilitating metabolic genetic diseases.","totalSpending":325000,"filings":11,"yearlySpending":[{"year":2019,"income":0},{"year":2020,"income":130000},{"year":2021,"income":195000},{"year":2022,"income":0}],"issues":[{"code":"PHA","display":"Pharmacy"},{"code":"HCR","display":"Health Issues"}],"firms":["THE KPM GROUP DC LLC"],"lobbyists":["PATROSKI LAWSON","BENJAMIN MASON","KATHERINE LANDES","JACOB JACKSON","YOKO ROSENBAUM"],"govEntities":["SENATE","White House Office","Centers For Medicare and Medicaid Services (CMS)","HOUSE OF REPRESENTATIVES"],"sampleDescriptions":["Drug Pricing and Innovation \n\nH.R.3 - Elijah E. Cummings Lower Drug Costs Now Act\n\nS.2543 - Prescription Drug Pricing Reduction Act of 2019","Drug pricing and innovation\n\nH.R.3 - Elijah E. Cummings Lower Drug Costs Now Act\n\nS.2543 - Prescription Drug Pricing Reduction Act of 2019","New Born Screening, Orphan Drug Act, FDA","New Born Screening Act, Drug Pricing, Priority Review Voucher Program","Drug pricing"]}